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The breakdown of health care in Syria under the present conﬂict
has been highlighted in ProMED reports on the increasing risk of
leishmaniasis1–4 and rabies.5 However, these reports merely
reﬂect the drastic deterioration in health care. A recent report
from Me´decins Sans Frontie`res6 highlights not only the destruction
of health care facilities and the difﬁculties in treating injured
people, but also describes the absence of childhood immunizations
in many areas, lack of pharmaceuticals including antibiotics, and
the lack of access to clean water and surge in diarrhea cases.
Furthermore, medical facilities and staff have been deliberately
targeted;7 the Independent International Commission of Inquiry
on Syria wrote in a report this month, ‘‘Medical personnel and
hospitals have been deliberately targeted and are treated by
parties to the conﬂict as military objectives.’’8,9 The conﬂict is
expected to reverse the recent gains seen in the falling infant
mortality rate and increased childhood immunization rate.10
Under these circumstances a surge in infectious diseases in both
Syria and neighboring countries can be expected.* Corresponding author. Tel.: +45 7845 2817; fax: +45 7845 2870.
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A novel coronavirus with a high mortality has been described
in Saudi Arabia, Qatar, Abu Dhabi, and Jordan.11 So far, the virus
infection has shown a high mortality, and person to person
transmission has been seen within a family.12 As at July 8, 2013,
80 cases have been diagnosed, with a fatal outcome in 45
deaths.28
A recent case diagnosed in Italy was infected in Jordan, as were
some of the ﬁrst cases.13 Thus the MERS-CoV may also exist in
Syria, and the refugee camps pose a particular threat to airborne
transmission. At present the reservoir of the infection is not known
and neither are its transmission potential and the proportion of
mild cases.
3. Upper respiratory tract, gastrointestinal, and skin infections
Hepatitis A virus, enterovirus, and bacterial infections due to
Salmonella, Shigella, and Escherichia coli will appear due to
contaminated water. Upper respiratory tract infections will
increase and epidemics of inﬂuenza are to be expected. The
crowded living conditions combined with a lack of health care
facilities will result in an increase in tuberculosis. In 2009 it was
estimated that Syria had 26 (range 22–31) new cases of
tuberculosis per 100 000 population.14 Inﬂuenza is a threat and
if introduced will probably spread rapidly in the refugee camps.
Infections with common soil helminths such as Ascaris are
expected to increase and cholera is an imminent risk. Skin
infections like scabies are expected to be prevalent.
Schistosoma haematobium is found in the governorate of Al-
Raqqah in Syria, whereas Turkey and Lebanon are free of
schistosomiasis and there are only a few foci found in Jordan.15
With the poor sanitary conditions in the refugee camps, contami-
nation of fresh water sources from infected refugees is a risk.
4. Measles and other vaccine-preventable infections
The childhood vaccination program is not functioning in areas
affected by the war, but the United Nations Children’s Fund
(UNICEF) has supported vaccination in refugee camps and
populations living close to refugee camps against measles
and polio.16 A measles and polio vaccination campaign began in
late November 2012. As of December 12, 2012, 948 000 childrenses. Published by Elsevier Ltd. All rights reserved.
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measles, with the campaign still in progress.16 The Ministry of
Health of Jordan in collaboration with the World Health
Organization, UNICEF, and the United Nations High Commissioner
for Refugees (UNHCR) completed a vaccination campaign against
measles at the Zaatari refugee camp in April 2013, immunizing 98%
of the target population of some 90 000 people – mainly new
arrivals – between the ages of 6 months and 30 years.17
5. Vector-borne infections
5.1. Leishmaniasis
Several reports indicate that cutaneous leishmaniasis in on the
increase. Cutaneous leishmaniasis is caused by Leishmania tropica,
and 30 000 cases were reported in 2008.18 Visceral leishmaniasis is
rare but is found in Aleppo and from there towards the Turkish
border. The reservoir for L. tropica is small rodents and for
Leishmania infantum is dogs.17
5.2. Dengue fever
Dengue is endemic in the western and southern regions of Saudi
Arabia,19 and the presence of the vector for dengue fever, Aedes
albopictus, was reported from Lebanon and Syria for the ﬁrst time
in 2007.20
There is a real risk of the emergence of dengue fever in Syria
under the present conditions.
5.3. Malaria
Syria was endemic for malaria until recently. In the World
Malaria Report for 2005 only limited transmission in a few areas in
the northeastern part of the country towards the border with Turkey
and Iraq was reported.21 Malaria in Turkey has been largely
controlled, and in 2011 only four relapses of Plasmodium vivax were
reported; Turkey aimed to interrupt malaria transmission by 2012.22
Thus the risk of large outbreaks of malaria is limited, as transmission
has almost been controlled in Syria and neighboring countries.
However, a transmission potential exists and a febrile patient with
no speciﬁc symptoms should be investigated for malaria.
6. Zoonoses
6.1. Rabies
There is little doubt that rabies circulation in animals, especially
dogs, is increasing in Syria, with an expected increased risk of
rabies in the human population too. Rabies in dogs appears
widespread, as is apparent from information gathered on the
Israeli side of the Syrian border.23 From 2005 to 2012 Syria
reported between two and 16 outbreaks in animals annually and
16 human cases.24
6.2. Crimean-Congo hemorrhagic fever (CCHF)
CCHF is a viral zoonotic disease transmitted by ixodid ticks and
has been increasing in Turkey;25 livestock has been identiﬁed as
the source of infection in one study.26
6.3. Brucellosis
Breakdown in veterinary public health systems will result in the
re-emergence of brucellosis.27 Brucellosis is common in cattle and
sheep in Jordan and is also seen in goats.15With a lack of veterinary
control, brucellosis will increase in Syria.7. Conclusions
Many of the infections like leishmaniasis, tuberculosis, and
brucellosis have a long incubation time and refugees will have
these infections with them, with the risk of reintroducing them in
neighboring countries. An increase in cases of leishmaniasis has
already been reported from Syria and will most probably also be
seen in the refugee population.
Epidemics of bacterial meningitis and gastrointestinal infec-
tions like hepatitis A, enterovirus, and Giardia can be expected.
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